Based on the hypothesis that pharmacological enhancement of autophagy clearance of tau can rescue tauopathy phenotypes, and to further advance the concept that patient-derived cellular models can provide a valuable and clinically-relevant tool for drug discovery39,40, we performed a small-molecule screen to identify activators of autophagy in human ex vivo neurons. Here, MAPT is linked to tauopathy.